Statement Of Cash Flows [Abstract]

PureTech Health plc - Filing #1880925

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
138,924,000 USD
5,050,000 USD
6,114,000 USD
Adjustments for decrease (increase) in trade and other receivables
7,734,000 USD
617,000 USD
529,000 USD
Adjustments for decrease (increase) in other current assets
862,000 USD
5,350,000 USD
3,371,000 USD
Adjustments for gains (losses) on change in fair value of derivatives
8,163,000 USD
800,000 USD
USD
Adjustments for gain (loss) on disposals, property, plant and equipment
138,000 USD
53,000 USD
66,000 USD
Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates
27,251,000 USD
USD
USD
Cash flows from (used in) investing activities [abstract]
Purchase of interests in associates
19,961,000 USD
USD
USD
Purchase of investments other than investments accounted for using equity method
USD
USD
10,000,000 USD
Purchase of financial instruments, classified as investing activities
248,733,000 USD
USD
USD
Proceeds from sales or maturity of financial instruments, classified as investing activities
50,000,000 USD
USD
30,116,000 USD
Cash flows from (used in) financing activities [abstract]
Proceeds from exercise of options
332,000 USD
352,000 USD
1,036,000 USD
Proceeds from exercise of warrants
USD
USD
92,000 USD
Proceeds from issue of preference shares
USD
37,610,000 USD
13,750,000 USD
Proceeds from non-current borrowings
USD
USD
14,720,000 USD
Proceeds from current borrowings
USD
USD
68,000 USD
Proceeds from issue of bonds, notes and debentures
393,000 USD
2,215,000 USD
25,000,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.